Beth Sence

Beth Sence is an experienced professional in the pharmaceutical industry, currently serving as a Psychiatry Account Specialist at Neurocrine Biosciences since April 2024. Previously, Sence held roles such as Senior Clinical Specialist at Indivior, where responsibilities included promoting injectable medication for Substance Use Disorder. Other notable positions include Neurology Account Specialist at Adamas Pharmaceuticals, where a complex therapy for Parkinson’s Disease was relaunched, and Medical Sales Specialist at Kaleo Pharmaceuticals, focusing on an injectable opioid reversal agent. Sence has a strong track record in specialty pharmaceuticals, having worked on various product launches and re-launches across multiple therapeutic areas, including pain management and addiction. Sence holds a BA in Communication Arts from the University of Cincinnati.